Skip to main content

Table 1 The baseline characteristics of PDAC patients included in this study

From: Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma

  TMB_low (n = 67) TMB_high (n = 68)  
Age (year)a 66.22 ± 1.33 63.82 ± 1.40 p = 0.22
Gender (female %) 32 (49.2%) 27 (40.3%) p = 0.38
Location (head %) 59 (88.1%) 46 (67.7%) p = 0.007*
T3T4 (%) 56 (83.6%) 61 (89.7%) p = 0.32
N1 (%) 55 (80.9%) 44 (66.7%) p = 0.07
AJCC pathologic tumor stage (a2 ~) 56 (83.6%) 46 (68.7%) p = 0.07
KRAS 61 (91%) 64 (94.1%) p = 0.53
Tumor puritya 0.27 ± 0.02 0.47 ± 0.02 p < 0.0001*
  1. *Statistically significant
  2. aData was presented as mean ± deviance